価格表

在庫・価格 : 2024年05月03日 00時43分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-ACTN4, Mouse-Mono(13G9) <Anti-Actin α4>
データシート
DH0003 ABNアブノヴァ
Abnova Corporation
100 μg 本製品は取扱中止になりました 追加

在庫・価格 : 2024年05月03日 00時43分 現在

Anti-ACTN4, Mouse-Mono(13G9) <Anti-Actin α4>

  • 商品コード:DH0003
  • メーカー:ABN
  • 包装:100μg
  • 本製品は取扱中止になりました
使用文献
No. 文献情報 備考 参照
1 Kikuchi S et al. Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas. Clin. Cancer Res. 2008 Sep;14(17):5348-56
Kikuchi S et al
2008/01/01
PubMed
2 Yamamoto S et al. Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance. Mod. Pathol. 2009 Apr;22(4):499-507
Yamamoto S et al
2009/01/01
PubMed
3 Noro R et al. Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification. Ann. Oncol. 2013 Oct;24(10):2594-600
Noro R et al
2013/01/01
PubMed
4 Kakuya T et al. Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer. Int J Oral Maxillofac Surg 2017 Aug;46(8):968-976
Kakuya T et al
2017/01/01
PubMed
5 Nami Miura et al., Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4., Oncotarget. 2016 April 21.

PubMed
6 Miura N et al. Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4. Oncotarget 2016 May;7(22):33165-78
Miura N et al
2016/01/01
PubMed
  • No.: 1
  • 文献情報:
    Kikuchi S et al. Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas. Clin. Cancer Res. 2008 Sep;14(17):5348-56
    Kikuchi S et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Yamamoto S et al. Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance. Mod. Pathol. 2009 Apr;22(4):499-507
    Yamamoto S et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Noro R et al. Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification. Ann. Oncol. 2013 Oct;24(10):2594-600
    Noro R et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kakuya T et al. Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer. Int J Oral Maxillofac Surg 2017 Aug;46(8):968-976
    Kakuya T et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Nami Miura et al., Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4., Oncotarget. 2016 April 21.

  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Miura N et al. Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4. Oncotarget 2016 May;7(22):33165-78
    Miura N et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed